AstraZeneca’s head of sustainability on the pharma giant’s climate efforts
The company has set lofty goals, including decarbonizing its value chain by 2030.
Maia is a Minnesota-based senior reporter and founding reporter of Healthcare Brew, where she covers the pharmacy industry, women’s health, digital health, and how venture capital is shaping healthcare. She previously worked as a fellow covering the aerospace industry at Insider, as well as a healthcare reporter for Becker's Hospital Review. She has won an award from the Society of Professional Journalists for her work.
The company has set lofty goals, including decarbonizing its value chain by 2030.
We spoke with leaders on how they’ve fared so far this year and what they’re focused on next.
The sector’s landscape has changed rapidly in the last few years.
The new name opens research on the condition up to more NIH funding, an expert explains.
The company wants to keep physicians in the field of medicine for as long as possible, she said.
The Trump administration has paused new enrollment in the areas for six months.
Since the 2022 Dobbs decision, there have been a number of changes to abortion access.
The union was formed specifically to address pharmacy workers’ concerns.
Fraud exists, but experts say it’s not as rampant as the Trump administration claims.
The company bought Omnicare for $12.7 billion in 2015 and is selling it for $250 million.